Rua investors approve Zalm deal

Jan 19, 2022 | Featured, Latest News

20.1.22 Rua Bioscience CEO, Rob Mitchell, says the result of yesterday’s special meeting that yesterday approved the acquisition of Zalm Therapeutics is an important moment for the company. Rua Bioscience (NZX: RUA) shareholders have overwhelmingly approved the purchase of Zalm, throwing further shareholder weight behind the company’s bid to become New Zealand’s premier medicinal cannabis […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Rua investors approve Zalm deal

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here